Article Text

Download PDFPDF
Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn’s disease and ulcerative colitis
  1. A Sturm1,
  2. A Z A Leite2,
  3. S Danese2,
  4. K A Krivacic2,
  5. G A West2,
  6. S Mohr3,
  7. J W Jacobberger4,
  8. C Fiocchi2
  1. 1Division of Gastroenterology, Department of Medicine, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA, and Department of Medicine, Division of Gastroenterology and Hepatology, Charité-Universitätsmedizin Berlin, Campus Virchow Clinic, Berlin, Germany
  2. 2Division of Gastroenterology, Department of Medicine, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
  3. 3Division of Endocrinology, Department of Medicine, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
  4. 4Ireland Cancer Research Center, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
  1. Correspondence to:
    Dr C Fiocchi
    Division of Gastroenterology, University Hospitals of Cleveland, Case Western Reserve University School of Medicine (BRB 425), 10900 Euclid Ave, Cleveland, Ohio, 44106-4952, USA; cxf18po.cwru.edu

Abstract

Background: Different abnormalities of T cell effector function distinguish Crohn’s disease (CD) from ulcerative colitis (UC). Because cell cycling determines effector function, pathogenic events in CD and UC may depend on cell cycle changes unique to each condition.

Methods: Cell cycle kinetics, cycle regulatory molecule expression, apoptosis, caspase and telomerase activity, and cellular expansion were evaluated in CD2 and CD3 activated control, CD, and UC lamina propria T cells.

Results: Compared with normal cells, CD T cells cycle faster, express increased phosphorylated Rb and decreased phosphorylated p53 levels, display less caspase activity but more telomerase activity, die less, and undergo vigorous cellular expansion. In contrast, UC T cells cycle slower, express normal levels of phosphorylated Rb and p53, display more caspase activity but have no telomerase activity, die more, and have a limited capacity to expand.

Conclusions: T cell cycle abnormalities in CD indicate a state of hyperreactivity compatible with loss of tolerance, but a hyporeactive state compatible with anergy in UC. Thus distinct and divergent T cell cycle characteristics underlie the pathogenesis of the two main forms of inflammatory bowel disease.

  • CDK, cyclin dependent kinase
  • IBD, inflammatory bowel disease
  • LPT, lamina propria T cells
  • CD, Crohn’s disease
  • UC, ulcerative colitis
  • Rb, retinoblastoma protein
  • BrdU, bromodeoxyuridine
  • PI, propidium iodide
  • CFDA SE, carboxyfluorescein diacetate succinimidyl ester
  • IL, interleukin
  • IFN, interferon
  • mAb, monoclonal antibody
  • PMA, phorbol myristate acetate
  • PHA, phytohaemagglutinin
  • FITC, fluorescein isothiocyanate
  • RPE, R-phycoerythrin
  • PBS, phosphate buffered saline
  • TRAP, telomeric repeat amplification protocol
  • mucosal immunity
  • cell cycle
  • cyclins
  • telomerase
  • retinoblastoma protein
  • inflammatory bowel disease
  • Crohn’s disease
  • ulcerative colitis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles